- Home
- FAMI vs SLRX Comparison
FAMI vs SLRX Comparison
Compare FAMI & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FAMI
- SLRX
- Stock Information
- Founded
- FAMI 2015
- SLRX N/A
- Country
- FAMI China
- SLRX United States
- Employees
- FAMI N/A
- SLRX N/A
- Industry
- FAMI Packaged Foods
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- FAMI Consumer Staples
- SLRX Health Care
- Exchange
- FAMI Nasdaq
- SLRX Nasdaq
- Market Cap
- FAMI 2.2M
- SLRX 1.8M
- IPO Year
- FAMI 2018
- SLRX N/A
- Fundamental
- Price
- FAMI $1.82
- SLRX $0.75
- Analyst Decision
- FAMI
- SLRX
- Analyst Count
- FAMI 0
- SLRX 0
- Target Price
- FAMI N/A
- SLRX N/A
- AVG Volume (30 Days)
- FAMI 36.8K
- SLRX 229.6K
- Earning Date
- FAMI 08-08-2025
- SLRX 08-08-2025
- Dividend Yield
- FAMI N/A
- SLRX N/A
- EPS Growth
- FAMI N/A
- SLRX N/A
- EPS
- FAMI N/A
- SLRX N/A
- Revenue
- FAMI $64,131,332.00
- SLRX N/A
- Revenue This Year
- FAMI N/A
- SLRX N/A
- Revenue Next Year
- FAMI N/A
- SLRX N/A
- P/E Ratio
- FAMI N/A
- SLRX N/A
- Revenue Growth
- FAMI N/A
- SLRX N/A
- 52 Week Low
- FAMI $1.43
- SLRX $0.45
- 52 Week High
- FAMI $7.43
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- FAMI 57.05
- SLRX 47.25
- Support Level
- FAMI $1.77
- SLRX $0.60
- Resistance Level
- FAMI $2.12
- SLRX $0.70
- Average True Range (ATR)
- FAMI 0.17
- SLRX 0.10
- MACD
- FAMI 0.01
- SLRX 0.00
- Stochastic Oscillator
- FAMI 47.50
- SLRX 48.97
About FAMI Farmmi Inc.
Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.